Tandem Diabetes Care Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. I am Travis Steed, medical device analyst at Barclays. And up next this afternoon, we're pleased to have Tandem Diabetes. John Sheridan, President and CEO; Leigh Vosseller, Executive Vice President and CFO; and Susan Morrison, is also joining us as well, Executive Vice President, Chief Administrative Officer and Head of Investor Relations. So welcome. I'm glad you could join us today virtually. Hopefully next year, we'll be in person in Miami.
So just wanted to start out some of the long term, you're one of the few companies that really had long-term guidance and kept long-term guidance through COVID. You've talked about 500,000 patients in 2024. And just trying to think about, how do you feel about that number today? And do you think more of that's going to come from the U.S. now that some of the international markets are potentially a bit more challenged with COVID?
And John, I think you're still on mute.
How about that?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
